Table 2.
PSP extract reduces hepatic lipid peroxidation in rats treated with DEN/CCl4.
Experimental Groups |
Group I |
Group II |
Group III |
Group IV |
Group V |
Group VI |
---|---|---|---|---|---|---|
LPO (nmol/g liver) (mean ± SD) |
153.02 ± 27.58 | 217.03 ± 18.81 | 134.28 ± 20.72 | 147.19 ± 18.04 | 105.39 ± 20.38 | 144.43 ± 8.25 |
F (p) | 20.746* (<0.001) | |||||
p1 | <0.001* | <0.112 | 0.614 | <0.001* | <0.458 | |
p2 | <0.001* | <0.001* | <0.001* | <0.001* | ||
p3 | 0.002* | |||||
p4 | 0.268 |
F: F test (ANOVA), p1: p value of LSD test between negative control and other groups, p2: p value of LSD test between group II and group III, IV, V and VI, p3: p value of LSD test between group III and group V, p4: p value of LSD test between group IV and group VI, *: Statistically significant at p ≤ 0.05.